News & Updates

Magnetic seizure therapy for bipolar mania drives high response, preserves language function
Magnetic seizure therapy for bipolar mania drives high response, preserves language function
17 May 2024 byJairia Dela Cruz

Individuals with bipolar mania appear to respond well to magnetic seizure therapy (MST) while sustaining fewer effects on language function, with the response rate not significantly different from that seen with electroconvulsive therapy (ECT), as shown in a pilot study.

Magnetic seizure therapy for bipolar mania drives high response, preserves language function
17 May 2024
Psilocybin may help ease depression symptoms
Psilocybin may help ease depression symptoms
11 May 2024 byStephen Padilla

Treatment with psilocybin significantly improves the symptoms of depression, particularly when using self-report scales and when individuals have used psychedelics in the past, results of a systematic review and meta-analysis have shown.

Psilocybin may help ease depression symptoms
11 May 2024
More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
09 May 2024 byKanas Chan

Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide reported more fatigue, depression and deterioration in perceived cognitive ability, and slower reaction time than those receiving abiraterone acetate, according to results of the ACE study.

More evidence supports enzalutamide’s link with poorer mood and cognitive outcomes in mCRPC
09 May 2024